Loading...
TVGN is not a good buy right now. With no Intellectia buy signals, a clearly bearish technical setup, accelerating insider selling, and weak fundamentals (no revenue and ongoing losses), the odds favor further downside or choppy action rather than an immediate upside move—especially for an impatient investor who doesn’t want to wait for a cleaner entry.
Trend is bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), indicating sustained downtrend pressure. MACD histogram is negative (-0.000265) and expanding lower, reinforcing weakening momentum. RSI_6 ~33.8 is near oversold but still labeled neutral here—more consistent with 'weak/pressed' conditions than a strong reversal signal. Price is sitting near key support: S1 ~0.291 (post-market ~0.2917), with next support S2 ~0.269. Immediate resistance levels are Pivot ~0.325 and R1 ~0.36; the stock would need to reclaim ~0.325 convincingly to improve the near-term outlook. Pattern-based projection also leans negative: estimated -0.29% next day, -1.93% next week, -2.79% next month, suggesting downside drift remains the base case.
Board evaluating a potential one-time special cash dividend if specific financial milestones are achieved (could improve sentiment if milestones are credible/near-term). Modified long-term incentive program tied to revenue milestones; stated goal to launch four blockbuster products by 2030 (long-dated upside narrative if execution improves).
Insiders are selling, with selling amount up ~140.46% over the last month—typically a bearish sentiment signal. Technical momentum is deteriorating (bearish MA stack + negative/expanding MACD). Fundamental profile remains weak (no revenue in latest quarter and continuing net losses). Dividend discussion is conditional on milestones and not an actual declared dividend, which can create headline pop without near-term follow-through.
Latest quarter: 2025/Q3. Revenue was 0 (no YoY growth), indicating the business is still pre-revenue or not yet scaling. Net income was -$5.86M (slightly worse YoY, -0.80%), and EPS was -0.03. Overall: ongoing losses with no revenue traction—no clear sign of improving operating leverage yet.
No analyst rating / price target trend data was provided, so a Wall Street pros/cons consensus cannot be confirmed from the dataset. Based on available information only: pros are potential corporate actions (conditional special dividend) and incentive alignment; cons are lack of revenue, ongoing losses, and heavy insider selling.